Background: China is one of 30 countries with a high tuberculosis (TB) burden, and poor adherence to TB treatment is one of the biggest challenges for TB control. We aimed to explore the barriers and facilitators of treatment adherence among drug-sensitive tuberculosis (DS-TB) patients under the "Integrated model" in Western China, to provide evidence-based treatment and control regimens for DS-TB patients to improve adherence behaviours.

Methods: Both qualitative and quantitative research methods were used to explore the factors associated with self-reported adherence (SRA) behaviours. Questionnaire surveys with DS-TB patients and in-depth interviews with leaders from the Centers for Disease Control and Prevention (CDC) and community health sectors (CHCs), healthcare workers (HCWs) from CHCs, and DS-TB patients were conducted.

Results: A total of 459 eligible patients were included in the quantitative survey, and two patients and 13 healthcare providers were included in the in-depth interviews. The percentage of patients who experienced a missed dose, lack of follow-up sputum examination, and interrupted treatment were 19.0%, 11.3%, and 9.2%, respectively. Patients aged 20-39 had a higher risk of missed dose [OR (95% CI): 2.302 (1.001-5.305)] and a lower risk of interrupted treatment [OR (95% CI): 0.278 (0.077-0.982)] than patients more than 60 years. Patients who were of Han ethnicity (OR [95% CI]: 0.524 [0.301-0.912]) received psychological support (OR [95% CI]: 0.379 [0.144-0.998]) from their family and had a lower risk of missed doses. Patients who had drug side effects had a higher risk of interrupted treatment (OR [95% CI]: 2.587 [1.237-5.412]). Patients who possessed higher knowledge had a lower risk of lack of follow-up sputum examination [OR (95% CI): 0.817 (0.673-0.991)]. The results of the qualitative study also reported that patients' poor TB knowledge was the main reason for their non-SRA behaviours.

Conclusions: Patient-centred strategies should be implemented to improve health literacy and strengthen psychological support. More effective case management should be designed and implemented based on different patient characteristics to improve adherence behaviours in further studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889779PMC
http://dx.doi.org/10.1186/s12879-022-07208-6DOI Listing

Publication Analysis

Top Keywords

ds-tb patients
20
patients
13
interrupted treatment
12
[or 95%
12
lower risk
12
[95% ci]
12
adherence sra
8
sra behaviours
8
patients "integrated
8
"integrated model"
8

Similar Publications

Background: Other microbial infections in pulmonary tuberculosis (TB) patients pose significant challenges, complicating treatment outcomes and potentially increasing mortality rates. This study aims to characterize the bacterial and fungal infections profiles in pulmonary TB patients.

Materials And Methods: A retrospective cross-sectional analysis was conducted at Adam Malik Hospital in Medan, Indonesia, from June 2020 to May 2022, involving inpatients diagnosed with drug-sensitive or drug-resistant TB.

View Article and Find Full Text PDF

Accessibility and TB patient satisfaction in Nigeria.

Int J Tuberc Lung Dis

December 2024

School of Population Health, University of New South Wales, Sydney, NSW, Australia.

BACKGROUNDNigeria ranks first in Africa and sixth among countries with a high Tuberculosis burden globally. The increasing incidence of drug resistance following poor treatment adherence among drug-susceptible TB (DS-TB) patients necessitates reviewing TB services in Nigeria. This study explored accessibility and patient-reported experiences in newly established TB treatment facilities.

View Article and Find Full Text PDF

Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis.

Infection

November 2024

Department of Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Article Synopsis
  • The study investigates the serum levels of isoniazid and rifampicin in drug-sensitive TB patients treated between 2019 and 2023, focusing on sex-specific differences in drug levels.
  • The research found that while there were no significant differences in isoniazid levels between sexes, female patients had higher rifampicin levels compared to male patients despite similar weight-adjusted dosing.
  • Adverse effects were more prevalent in women during treatment, highlighting the need for clinicians to consider sex differences in therapeutic drug monitoring (TDM) for TB treatment.*
View Article and Find Full Text PDF

Molecular characteristics of drug-susceptible Mycobacterium tuberculosis clinical isolates based on treatment duration.

Osong Public Health Res Perspect

October 2024

Division of Bacterial Disease Research, Center for Infectious Disease Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.

Background: In this study, we performed comparative genomic and transcriptomic analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with drug-susceptible tuberculosis (DS-TB). The clinical isolates were categorized based on treatment duration: standard 6 months or >6 months.

Methods: Study participants were recruited from a 2016 to 2018 tuberculosis cohort, and clinical M.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the financial burden of tuberculosis (TB) on patients in Myanmar, particularly those utilizing private providers in public-private mix (PPM) schemes, despite TB services being generally free.
  • - A survey of 695 adults revealed that patients incurred a median total cost of approximately $53.4 for TB treatment, with the most significant expenses occurring during the pre-treatment phase and clinic visits.
  • - Alarmingly, about 34.5% of patients faced catastrophic health expenditure, defined as spending over 20% of their financial capacity on TB-related costs, highlighting the ongoing economic challenges despite available healthcare services.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!